Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus

被引：8
作者：
Canas, E
Pachon, J
GarciaPesquera, F
Castillo, JR
Viciana, P
Cisneros, JM
JimenezMejias, ME
机构：
[1] HOSP UNIV VIRGEN ROCIO,INFECT DIS UNIT,E-41013 SEVILLE,SPAIN
[2] HOSP UNIV VIRGEN ROCIO,DEPT NUCL MED,E-41013 SEVILLE,SPAIN
[3] HOSP UNIV VIRGEN ROCIO,CLIN PHARMACOL UNIT,E-41013 SEVILLE,SPAIN
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1996年 / 40卷 / 01期
关键词：
D O I：
10.1128/AAC.40.1.230
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Pharmacokinetic parameters of zidovudine (ZDV) were not altered in 16 patients receiving concomitant therapy with ZDV and trimethoprim-sulfamethoxazole by oral administration. ZDV areas under the concentration-time curves were (means +/- standard deviations) 1.80 +/- 0.70 and 1.69 +/- 0.64 mu g . h/ml in the absence and presence of trimethoprim-sulfamethoxazole, respectively. ZDV clearances were 1.57 +/- 0.61 and 1.74 +/- 0.66 liters/h/kg, respectively.
引用
收藏
页码：230 / 233
页数：4
相关论文
共 50 条
  • [31] The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus
    Lehmann, DF
    Liu, A
    Newman, N
    Blair, DC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (05) : 533 - 537
  • [32] Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients
    Ribera, E
    Pou, L
    Fernandez-Sola, A
    Campos, F
    Lopez, RM
    Ocaña, I
    Ruiz, I
    Pahissa, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3238 - 3241
  • [33] Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients
    Zhou, XJ
    Sheiner, LB
    D'Aquila, RT
    Hughes, MD
    Hirsch, MS
    Fischl, MA
    Johnson, VA
    Myers, M
    Sommadossi, JP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 121 - 128
  • [34] Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patients
    Wintergerst, U
    Rolinski, B
    Bogner, JR
    Notheis, G
    Goebel, FD
    Roscher, AA
    Belohradsky, BH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1143 - 1145
  • [35] PROLONGED ISOLATED FEVER DUE TO ATTENUATED EXTRACEREBRAL TOXOPLASMOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS WHO ARE RECEIVING TRIMETHOPRIM-SULFAMETHOXAZOLE AS PROPHYLAXIS
    ZYLBERBERG, H
    ROBERT, F
    LEGAL, FA
    DUPOUYCAMET, J
    ZYLBERBERG, L
    VIARD, JP
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) : 680 - 681
  • [36] Cutaneous adverse reactions and CD4+ cell counts in human immunodeficiency virus-infected patients receiving trimethoprim-sulfamethoxazole -: Reply
    Veenstra, J
    Lange, JMA
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) : 531 - 532
  • [37] A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus
    Marsh, BJ
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) : 754 - 755
  • [38] A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus
    Caumes, E
    Guermonprez, G
    Winter, C
    Katlama, C
    Bricaire, F
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) : 1313 - 1314
  • [39] Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children
    Autmizguine, Julie
    Melloni, Chiara
    Hornik, Christoph P.
    Dallefeld, Samantha
    Harper, Barrie
    Yogev, Ram
    Sullivan, Janice E.
    Atz, Andrew M.
    Al-Uzri, Amira
    Mendley, Susan
    Poindexter, Brenda
    Mitchell, Jeff
    Lewandowski, Andrew
    Delmore, Paula
    Cohen-Wolkowiez, Michael
    Gonzalez, Daniel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [40] DAPSONE, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    EDELSON, PJ
    METROKA, CE
    FRIEDMANKIEN, A
    ANNALS OF INTERNAL MEDICINE, 1985, 103 (06) : 963 - 963
12345